HPO, Anticipates Joint Growth with Denpus and Its Subsidiary

NH Investment & Securities Report

[Asia Economy Reporter Hyungsoo Park] NH Investment & Securities analyzed on the 17th that HPIO is expected to grow centered on the premium brand Denps.

Sim Eui-seop, a researcher at NH Investment & Securities, introduced, "It is maintaining a high operating profit margin in the mid-10% range," and "The probiotic products are manufactured using raw materials supplied by Christian Hansen, a Danish probiotic strain company."

The Baeksuo product launched by HPIO at the end of last year continues to perform well in the home shopping channel. Sales have steadily increased through product renewal. As online channel sales increase mainly through the direct mall, profitability is also expected to improve.

Researcher Sim said, "We also expect new business expansion and performance growth through subsidiaries," and explained, "The premium pet brand subsidiary Copenhagen Recipe recently launched organic dog food."

Researcher Sim predicted, "The subsidiary Biopharm is steadily growing and expanding its third factory," and "It will contribute to next year's performance."

In addition, he added, "Sales of health functional foods for growing children from the Chinese corporation are also increasing," and "The consolidated performance reflecting the distribution company Geo Infotech, acquired at the end of last year, will also contribute to improving performance."

This content was produced with the assistance of AI translation services.